Cornerstone Therapeutics Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter
June 13, 2013 09:08 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwired - Jun 13, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) ("Cornerstone" or the "Company") today announced that on June 11, 2013 the Company received a Paragraph IV...
Cornerstone Therapeutics Reports First Quarter 2013 Financial Results
May 09, 2013 07:00 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwired - May 9, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX)
Net revenue increased 71% compared to first quarter of 2012
Net income...
Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights to PERTZYE(R) (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis
May 09, 2013 06:45 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwired - May 9, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent...
REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call
May 08, 2013 08:00 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwired - May 8, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, May 9, 2013, to discuss...
Cornerstone Therapeutics to Host First Quarter 2013 Conference Call
May 02, 2013 18:30 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwired - May 2, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, May 9, 2013, to discuss...
Cornerstone Therapeutics Inc. Announces Retention of Advisors
March 20, 2013 16:45 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Mar 20, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) (the "Company") announced today that the Special Committee of its Board of Directors (the "Special Committee")...
Cornerstone Therapeutics Reports Fourth Quarter and Fiscal Year 2012 Financial Results
March 14, 2013 07:00 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Mar 14, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the U.S. hospital and adjacent...
Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2012 Conference Call
March 07, 2013 18:30 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Mar 7, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, March 14, 2013, to discuss its...
Cornerstone Therapeutics Inc. Announces Appointment of Special Committee
February 25, 2013 07:30 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Feb 25, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) (the "Company") announced today that its Board of Directors had appointed a special committee comprised of five...
Cornerstone Therapeutics Inc. Announces Receipt of Take-Private Proposal From Its Majority Stockholder
February 20, 2013 00:00 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Feb 20, 2013) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) (the "Company") announced today that its Board of Directors has received a letter from Chiesi Farmaceutici SpA...